mobihealthnews
The new platform for will offer video visits for rare disease diagnosis and longitudinal care.
The new platform for will offer video visits for rare disease diagnosis and longitudinal care.
Business model is unsustainable due to a challenging reimbursement environment and escalating operating costs, company says.
The health tech giant reported lower-than-expected sales and profits in the first quarter, resulting in its shares plummeting.
GenAI company for health plans Alaffia Health and oncology-focused clinical-trial platform Klineo also secured funding.
The wearable-tech company broadened its reach to 56 markets worldwide, added Italian and Latin American Spanish to its app and appointed three C-suite executives.
Build your own newsfeed
Ready to give it a go?
Start a 14-day trial, no credit card required.